Patents by Inventor Mihaela Maria Pop

Mihaela Maria Pop has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Resveratrol-piperazine co-crystals
    Patent number: 11560358
    Abstract: The present document is directed to co-crystals of resveratrol and/or curcumin with piperazine and their use in medicine and/or as food and feed supplements.
    Type: Grant
    Filed: April 9, 2019
    Date of Patent: January 24, 2023
    Assignee: LETAVIS AB
    Inventors: Mihaela Maria Pop, Paula Vasilichia Bulieris, Ingemar Pongratz, Victor Fruth-Oprisan, Raul-Augustin Mitran
  • CO-CRYSTALS
    Publication number: 20210032210
    Abstract: The present document is directed to co-crystals of resveratrol and/or curcumin with piperazine and their use in medicine and/or as food and feed supplements.
    Type: Application
    Filed: April 9, 2019
    Publication date: February 4, 2021
    Inventors: Mihaela Maria POP, Paula VASILICHIA BULIERIS, Ingemar PONGRATZ, Victor FRUTH-OPRISAN, Raul-Augustin MITRAN
  • PROCESS FOR PREPARING NEW TIOTROPIUM SALTS, NEW TIOTROPIUM SALTS AS SUCH AND PHARMACEUTICAL COMPOSITIONS THEREOF
    Publication number: 20140316138
    Abstract: The invention relates to a process for preparing new tiotropium salts, these new tiotropium salts as such, pharmaceutical formulations containing them and their use for preparing a medicament.
    Type: Application
    Filed: July 3, 2014
    Publication date: October 23, 2014
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Mihaela Maria POP, Stéphanie MULDER HOUDAYER, Peter SIEGER, Michael P. PIEPER
  • Crystalline forms of tiotropium bromide
    Patent number: 7879871
    Abstract: The invention relates to a new crystalline forms of tiotropium bromide, processes for preparing them and their use for preparing a pharmaceutical composition for the treatment of respiratory complaints, particularly for the treatment of COPD (chronic obstructive pulmonary disease) and asthma.
    Type: Grant
    Filed: May 1, 2006
    Date of Patent: February 1, 2011
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Mihaela Maria Pop, Stéphanie Houdayer Mulder, Mimoun Lamkadmi